Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Sandoz blocked by UK court from seeking Xarelto profits
Europe
Sandoz blocked by UK court from seeking Xarelto profits
A High Court decision clarifies how cross-undertakings work in patent disputes, rejecting claims for exceptional remedies beyond compensation.   2 September 2025
UPC sees rising small molecule litigation with Pfizer in the hot seat
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
A rare “innovator v innovator” case puts Pfizer in the firing line over its COVID-19 drug, highlighting the Unified Patent Court as an attractive forum for ‘David vs Goliath’ scenarios, say experts.   29 August 2025
Alston & Bird partner with strong Japanese ties jumps to new firm
Careers
Alston & Bird partner with strong Japanese ties jumps to new firm
Bilingual litigator brings experience of handling IP disputes across multiple industries, from medical devices and pharmaceuticals to consumer electronics and apparel.   25 August 2025
MedTech
Chinese invisible braces maker hits back at infringement claims
The company has dismissed recent patent infringement claims from the Invisalign maker as “frivolous and entirely without merit,” pledging a vigorous defence.   22 August 2025
Americas
‘Loopholes’ in ITC orders? Blindsided Masimo takes aim at US customs
In a rare legal action, the medtech company claims the agency unlawfully let Apple reintroduce a feature on its watches that undermines an ITC ban.   21 August 2025
MedTech
Invisalign maker sues Chinese rival in Europe, US, and China
The $4 billion-a-year orthodontics company says its latest lawsuits defend “critical components” of its portfolio as rivals push cheaper alternatives.   21 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
The Japanese pharma company has defended a key patent for a treatment that achieved record 2024 sales of over $6 billion—but a patent cliff looms.   20 August 2025
Americas
Apple Watch revives key medtech feature after import ban
Several months after a US import ban sidelined a key Apple Watch feature, the tech giant is restoring a redesigned sensor to some models.   18 August 2025
Americas
Judge overturns Amgen’s $50m damages loss
A pair of patents behind an infringement case that proved expensive for Amgen have been found “unenforceable due to inequitable conduct”.   15 August 2025
Careers
Weil adds two more litigators from larger rival
The pair follow heads of tech and litigation out the door, bringing experience of representing clients before district courts, Federal Circuit, PTAB, and the ITC.   14 August 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.